STOCKWATCH
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultApr 30, 2026, 07:12 AM

MO Q1 Adjusted EPS $1.32 (+7.3%); Reaffirms Full-Year Guidance

AI Summary

Altria Group, Inc. reported a strong start to 2026, with Q1 adjusted diluted EPS growing 7.3% to $1.32 and net revenues increasing 3.2% to $5.428 billion. The company reaffirmed its full-year adjusted diluted EPS guidance of $5.56 to $5.72, reflecting confidence despite macroeconomic uncertainties. Altria also returned significant capital to shareholders through $280 million in share repurchases and $1.8 billion in dividends during the quarter.

Key Highlights

  • MO Q1 Adjusted diluted EPS rose 7.3% to $1.32, while reported diluted EPS increased over 100% to $1.30.
  • Net revenues increased 3.2% to $5.428 billion, with revenues net of excise taxes up 5.3% to $4.758 billion.
  • Reaffirms 2026 full-year adjusted diluted EPS guidance in the range of $5.56 to $5.72, representing 2.5% to 5.5% growth.
  • Repurchased 4.5 million shares for $280 million in Q1 2026, with $720 million remaining in the $2 billion program.
  • Paid $1.8 billion in dividends during the first quarter.
  • Smokeable products segment net revenues increased 2.9% to $4.758 billion, with adjusted OCI up 6.3%.
  • Oral tobacco products segment net revenues increased 2.3% to $669 million, with adjusted OCI up 0.2%.
  • Marlboro retail share of the total cigarette category was 39.7%, a decrease of 1.4 share points YoY.
MO
Medicinal Chemicals and Botanical Products
ALTRIA GROUP, INC.

Price Impact